
-
BioSig Technologies NASDAQ:BSGM BioSig Technologies is a medical technology company commercializing a proprietary biomedical signal processing platform designed to improve signal fidelity and uncover the full range of ECG and intra-cardiac signals (www.biosig.com).
Location: | Website: www.biosig.com | Industry: Surgical and Medical Instrument Manufacturing | Sector: Manufacturing
Market Cap
NaN
52 Wk Range
$ - $
Previous Close
$N/A
Open
$N/A
Day Range
N/A - N/A
Volume
N/A
Avg Volume
N/A
Enterprise Value
33.31M
Cash
142K
Avg Qtr Burn
-1.19M
Short % of Float
2.28%
Insider Ownership
14.80%
Institutional Own.
21.17%
Qtr Updated
12/31/24
Drug Pipeline
Powered by

Only showing assets and stage. See catalyst data with a free or premium account. Unlock more data with a free account.
Drug & Indication | Stage & Event | Catalyst Date |
---|---|---|
PURE EP™ (device) Details Heart disease, Medical device | Approved Quarterly sales | |
Merimepodib (MMPD) Details COVID-19 | Failed Discontinued |